Incidence and clinical relevance of the interactions and side effects of hypericum preparations;Häufigkeit und klinische relevanz der interaktionen und nebenwirkungen von hypericum-präparaten

Praxis

Volumn 89, Issue 50, 2000, Pages 2131-2140

  Schulz, V ^a  

^a NONE   (Germany)

Author keywords

Interactions; Side effects; St. John's wort extract

Indexed keywords

AMITRIPTYLINE; AMLODIPINE; COUMARIN ANTICOAGULANT; CYCLOSPORIN; DIGOXIN; ETHINYLESTRADIOL; FELODIPINE; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; MIDAZOLAM; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; NORTRIPTYLINE; PHENPROCOUMON; PROTEINASE INHIBITOR; THEOPHYLLINE; TRIAZOLAM; VERAPAMIL; WARFARIN;

ALLERGY; AREA UNDER THE CURVE; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM PERFORATUM; PHOTOSENSITIZATION; REVIEW; SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG INTERACTIONS; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; PLANT EXTRACTS; PLANTS, MEDICINAL; RISK FACTORS;

EID: 0034649555     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Ameer B., Weintraub R.A.: Drug interaction with grapefruit juice. Clin. Pharmacokin., 33, 103-121, 1997.
2. Araya O.S., Ford E.J.H.: An investigation of the type of photosensitization caused by the ingestion of St. John's Wort (Hypericum perforatum) by calves. J. Comp. Pathol., 91, 135-141, 1981.
3. Barbenel D.M., Yusufi B., O'Shea D., Bench C.J.: Mania in a patient receiving Testosterone replacement post orchidectomy taking St. John's Wort and sertraline. J. Psychopharmacol., 14, 84-86, 2000.
4. Bon S., Hartmann K., Kuhn M.: Johanniskraut: Ein Enzyminduktor? Schweiz. Apotheker Z., 16, 535-6, 1999.
5. Bove G.M.: Acute neuropathy after exposure to sun in a patient treated with St. John's Wort. Lancet, 352, 1121-2, 1998.
6. Brockmöller J., Reum T., Bauer S., Kerb R., Hübner W.D., Roots I.: Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in Humans. Pharmacopsychiatry, 30 (Suppl.), 94-101, 1997.
7. Czekalla J., Gastpar M., Hübner W.D., Jäger D.: The Effect of Hypericum Extract on Cardiac Conduction as seen in the Electrocardiogram Compared to that of Imipramine. Pharmacopsychiat., 30 (Suppl.), 86-88, 1997.
8. Ereshewsky B., Gewrtz N., Larn Y.W.F., Vega L.M., Ereshewsky L.: Determination of St. John's Wort differential metabolism at CYP2D6 and CYP3A4, using dextromathorphan probe methology. Poster 130, 39th Annual Meeting of the New Clinical Drug Evaluation Unit, Boca Raton, Florida, June 1-4, 1999.
9. Ernst E.: Second thoughts about safety of St. John's Wort. Lancet, 354, 2014-5, 1999.
10. Ernst E.: Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion, 13, 4-15, 2000.
11. Ernst E.: Interactions between synthetic and herbal medicinal products. Part 2: a systematic review of the direct evidence. Perfusion, 13, 60-70, 2000.
12. Fugh-Berman A.: Herb drug interactions. Lancet, 355, 134-138, 2000.
13. Gerloff T., Störmer E., Mrozikiewicz A.P.M., Roots I.: Hypericum perforatum (St. John's Wort) has no effect on protein expression of intestinal P-glycoprotein (MdrI) in the rat. Abstract, CPT 2000, Florenz, 2000.
14. Gewertz N., Ereshefsky B., Lam Y.W.F., Bonavides R., Ereshefsky L.: Determination of the differential effects of St. John's Wort on the CYPIA2 and NAT2 metabolic pathways using caffeine probe methodology. Poster 131, 39th Annual Meeting of the New Clinical Drug Evaluation Unit, Boca Raton, Florida, June 1-4, 1999.
15. Giese A.C.: Hypericism. Photochem Photobiol. Rev., 39, 229-255, 1980.
16. Golsch S., Vocks E., Rakoski J., Brockow K., Ring J.: Reversible Erhöhung der Photosensitivität im UV-B-Bereich durch Johanniskraut-Präparate. Der Hautarzt, 48, 249-252, 1997.
17. Gordon J.: SSRIs and St. John's Wort: possible toxicity? Am. Fam. Physician, 62, 31, 1998.
18. Gulick R.M., Mc Auliffe V., Holden-Wiltse J. et al.: Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. Ann. Intern. Med., 130, 510-514, 1999.
19. Harrer G., Payk T.R., Schulz V. (Hrsg.): Hypericum als pflanzliches Antidepressivum. Nervenheilkunde. 12, 268-366, 1993.
20. Jenike M.A. (ed.): Hypericum: A Naval Antidepressant. J. Geriatr. Psychiatry Neurol., 7 (Suppl. I), 1-68, 1994.
21. Johne A., Brockmöller J., Bauer S., Maurer A., Langheinrich M., Roots I.: Pharmacokinetic interaction of digoxin with an herbal extract from St. Johns Wort (Hypericum perforatum). Clin. Pharmacol. Ther., 66, 338-345, 1999.
22. Kerb R., Bauer S., Brockmöller J., Roots I.: Urinary 6-(-hydroxycortisol excretion rate is affected by treatment with hypericum extract. Abstract. Eur. J. Clin. Pharmacol., 52 (Suppl.), A 186, 1997.
23. Kerb R., Brockmöller J., Staffeldt B., Ploch M., Roots I.: Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrob Agents Chemother., 40, 2087-2093, 1996.
24. Lantz M.S., Buchalter E., Giambanco V.: St. John's Wort and antidepressant drug interactions in the elderly. J. Geriatr. Psychiatry Neurol., 12, 7-10, 1999.
25. Lohse M.J., Müller-Oerlinghausen B.: Psychopharmaka. In: Schwabe U., Paffrath D. (Hrsg.): Arzneiverordnungsreport, 1999. Springer Berlin-Heidelberg-New York, 488-512, 1999.
26. Markowitz J.S., De Vane C.L., Boulton D.W., Carson S.W., Nahas Z., Risch S.C.: Effect of St. John's Wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Pharmacology Letters, 66, 133-139, 2000.
27. Maurer A., Johne A., Bauer S., Brockmöller J., Donath F., Roots I., Langheinrich M., Hübner W.D.: Interaction of St. John's Wort extract with phenprocounum. Abstract. Eur. J. Clin. Pharmacol., 55, A 22, 1999.
28. Moses E.L., Mallinger A.: St. John's Wort: Three cases of possible mania induction. J. Clin. Psychopharmacol., 20, 115-117, 2000.
29. Müller W.E., Kasper S. (eds.): Hypericum Extract (LI 160) as a Herbal Antidepressant. Pharmakopsychiat., 30 (Suppl. II), 71-134, 1997.
30. Müller W.E., Chatterjee S.S. (eds.): Hyperforin and the Antidepressant Activity of St. John's Wort. Pharmacopsychiat., 31 (Suppl. I), 1-60, 1998.
31. Nebel A., Schneider B.J., Baker R.K., Kroll D.J.: Potential metabolic interaction between St. John's Wort and theophylline. Ann. Pharmacol., 33, 502, 1999.
32. Nierenberg A.A., Burt T., Matthews J., Weiss P.: Mania associated with St. John's Wort. Biol. Psychiatry, 46, 1707-8, 1999.
33. NN (1984) Monographie Hyperici herba (Johanniskraut). Bundesanzeiger, Nr. 228 vom 05.12.1984.
34. O'Breasail A.M., Argouarch S.: Hypomania and St. John's Wort. Can L Psychiatry, 43, 746-7, 1998.
35. Peet M.: Induction of mania with selective srotonin reuptake inhibitors and tricyclic antidepressants. Br. J. Psychiat., 164, 549-50, 1994.
36. Piscitelli S.C., Burstein A.H., Chaitt D., Alfaro R.M., Fallon J.: Indinavir concentration and St. John's Wort. Lancet, 355, 547-548, 2000.
37. Rey J.M., Walter G.: Hypericum perforatum (St. John's Wort) in depression: pest or blessing? MJA, 169, 583-586, 1998.
38. Roby C.A., Kantor E., Anderson G.D., Burstein A.H.: St. John's Wort impact on CYP3A4 activity. Poster 129, 39th Annual Meeting of the New Clinical Drug Evaluation Unit, Boca Raton, Florida, June 1-4, 1999.
39. Roots I., Johne A., Maurer A., Donath F., Bauer S., Brockmöller J.: Pharmakokinetische Arzneimittel-Interaktionen unter der Behandlung mit Johanniskraut. Abstract. 10. Jahrestagung der Gesellschaft für Phytotherapie, Münster, 1999.
40. Ruschitzka F., Meier P.J., Turina M., Lüscher T.F., Noll G.: Acute heart transplant rejection due to St. John's Wort. Lancet, 355, 548-9, 2000.
41. Schmidt U., Harrer G., Kuhn U., Berger-Deinert W., Luther D.: Wechselwirkungen von Hypericum-Extrakt mit Alkohol. Nervenheilkunde, 12, 314-319, 1993.
42. Schneck C.: St. John's Wort and hypomania. J. Clin. Psychiatry, 59, 12, 1998.
43. Schulz V.: Stellenwert von Hypericum-Extrakten in der Therapie leichter bis mittelschwerer Depressionen. In: Loew D., Blume H., Dingermann T. (Hrsg.): Phytopharmaka V - Forschung und klinische Anwendung. Steinkopff-Verlag, Darmstadt, 1999.
44. Schulz V., Hänsel R., Tyler V.E.: Rational Phytotherapy, 4th Edition. Springer, Berlin, Heidelberg, New York, 2000.
45. Williams L., Hill D.P., Davis J.A., Lowenthal D.T.: The influence of food on the absorption and metabolism of drugs: an update. Eur. J. Drug Metab. Pharmacokinet., 21, 201-211, 1996.
46. Yue Y.Y., Gerden B.: Letter to the editor. Lancet, 355, 576-7, 2000.